atezolizumab,cabozantinib
roche,exelixis
['abate', 'cabozantinib', 'bladder', 'atezo']
it was great to see deepak kilari, md, from the abstract on hcrn gu18-343: a phase ii study of cabozantinib in combination with atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer (abate) on display during the poster sessions today! #asco2022 
An independent nonprofit cancer research organization conducting multi-center investigator-initiated oncology studies since 1984.